Rybelsus

Product

Novo Nordisk's oral semaglutide brand for type 2 diabetes

3 stories

FDA Approves Eli Lilly's Oral Weight-Loss Drug, Entering Market Against Novo Nordisk

FDA Approves Higher-Dose Wegovy for Weight Loss Treatment

Wegovy Users Face Five Times Greater Risk of Sudden Sight Loss Than Ozempic Users